Cyntellect Raises $3M in Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellular analysis technologies company Cyntellect has raised $3 million in financing in an equity, debt, and warrant options sale, according to a filing with the US Securities and Exchange Commission.

Cyntellect’s technologies include in situ, microplate-based cytometry instruments for use in cell-based diagnostics and therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.